The gut microbiota profile in psoriasis: a Brazilian case-control study.

The pathogenesis of psoriasis, an immune-mediated chronic inflammatory skin disease, remains unclear. Studies have shown an association between psoriasis and intestinal inflammation; in this context, the influence of the gut microbiota on the immune response of psoriasis has become a focus of recent research. The present research evaluated the composition and diversity of the gut microbiota of 21 participants with psoriasis from a Brazilian referral dermatology service compared to 24 healthy controls. A stool sample was collected from each participant at the time of inclusion in the study, and the samples were analysed by sequencing the 16S rRNA gene. The recruitment of research participants involved matching between groups by sex, age, body mass index, comorbidities and smoking and the exclusion of several criteria that could potentially influence the gut microbiota and the interpretation of the data. There was an increase in the Dialister genus and Prevotella copri species in patients with psoriasis compared to the control group. A reduction in the Ruminococcus, Lachnospira and Blautia genera, as well as in the Akkermansia muciniphila species, was also verified in the psoriasis group compared to the control group. Furthermore, patients with psoriasis exhibited less gut microbiota diversity than controls.

Chemiluminescent ELISA with multi-epitope proteins to improve the diagnosis of canine visceral leishmaniasis.

Diagnosing canine visceral leishmaniasis (CVL) is difficult because clinical signs of the disease are non-specific and a many infected animals in endemic areas, as in Brazil, are asymptomatic. Serological tests are the most common diagnostic methods employed, but most have limitations. For this reason, the implementation of a rapid, sensitive, and specific diagnostic test for CVL has become increasingly important. In this study, we adapted a chemiluminescent enzyme-linked immunosorbent assay (CL ELISA), using two multi-epitope recombinant proteins (PQ10 and PQ20) and a crude Leishmania antigen produced using promastigotes of L. infantum, as antigens to detect CVL infection in animals from Belo Horizonte. To investigate cross-reactions, samples from dogs with other infections (babesiosis, ehrlichiosis and Trypanosoma cruzi) were tested. Assay performance validations were conducted to analyse parameters such as variability, reproducibility, and stability. CL ELISA sensitivity/specificity with PQ10 antigen was 93.1%/80.0%; with the PQ20 protein 93.1%/96.6%; and with the crude antigen 75%/73.3%. Inter-assay variability and inter-operator coefficient of variation were <7% and <15%, with PQ10 and PQ20, respectively. The accuracy of the CL ELISA was classified as excellent for PQ10 (AUC = 0.95) and PQ20 (AUC = 0.98) and moderate for the crude antigen (AUC = 0.77). The kappa score for qualitative agreement between two plate lots was excellent for PQ10 (0.89) and good for PQ20 (0.65). PQ20 remained more stable than PQ10. The CL ELISA with recombinant proteins is a promising tool to diagnose CVL.

Efeitos da fumaça de cigarro sobre a osteogênese e a resistência mecânica óssea em ratos / Effects of cigarette smoke on osteogenesis and bone mechanical resistance in rats

This paper reports a study of the effects of exposure to cigarette smoke on osteogenesis and the mechanical strength of bone in rats. Twelve male rats were separated into two groups (n=6): CT (control) and CI (cigarette). All the animals had free access to rat chow and water throughout the experiment. Group CI was exposed to the smoke of 6 cigarettes/day for 12 weeks. After 6 weeks of exposure to cigarette smoke, a defect was produced on the parietal bone and dense hydroxyapatite (DHA) ceramic bodies were implanted into cavities made surgically in the tibia of the animals, in each group. After surgery, the CT and CI groups returned to normal experimental conditions and, at the end of 12 weeks, they were euthanized, and their tibiae and parietal bones removed for histological processing, while the femurs were subjected to biomechanical tests in a MTS TestStar II three-point flexion module. Consumption of solid and liquid diet was satisfactory in both groups, all animals gaining weight throughout the experiment. CI animals showed a smaller volume of newly formed bone in the parietal defect (8.l9±0.2) and around the DHA implant in the tibia (33±0.5) than the rats in the CT group (14.4±0.5 and 39±1 respectively). The maximum force needed to break the femur was smaller in CI (119±3.2) than in CT (140±6.5). The results of this study led to the conclusion that exposure to cigarette smoke interfered with osteogenesis in the bone defect and around the DHA implant and reduced the maximum force required to completely break the femur, revealing that bone fragility can be caused by tobacco smoke.

O presente estudo teve como objetivo avaliar os efeitos da exposição à fumaça de cigarro sobre a osteogênese e a resistência mecânica do osso em ratos. Foram utilizados doze ratos machos, divididos em dois grupos (n=6): grupo CT (controle) e grupo CI (cigarro). Durante 12 semanas, os animais do grupo CI foram expostos à fumaça de seis cigarros/dia. Após seis semanas de exposição à fumaça de cigarro, uma falha óssea de 5mm foi produzida no osso parietal e corpos cerâmicos de hidroxiapatita densa (HAD) foram implantados em cavidade produzida cirurgicamente na tíbia dos animais do grupo CI e CT. Após as cirurgias, os animais retornaram aos protocolos experimentais e, ao término de doze semanas de experimentação, foram eutanasiados, as tíbias e os ossos parietais foram coletados para processamento histológico e os fêmures encaminhados para ensaio biomecânico em um módulo MTS TestStar II®. A exposição à fumaça do cigarro não interferiu no ganho de peso dos animais e os consumos de dieta líquida e sólida foram satisfatórios entre os grupos. Os animais do grupo CI apresentaram menor volume de osso neoformado na falha óssea (8,9±0,2) produzida no osso parietal e ao redor do implante de HAD na tíbia (33±0,5). A força máxima necessária para romper o fêmur dos animais foi menor no grupo CI (119±3,2) do que no grupo CT (140±6,5). Com bases nos resultados obtidos no presente trabalho, pôde-se concluir que a exposição à fumaça do cigarro interferiu na osteogênese da falha óssea e ao redor do implante de HAD, diminuiu a força máxima necessária para a ruptura completa dos fêmures e demonstrando a fragilidade óssea causada pelo hábito tabagista.

Modelos de avaliação da estabilidade de fármacos e medicamentos para a indústria farmacêutica / Stability models assessing of drugs and drug products for pharmaceutical industry

O estudo de estabilidade de fármacos e medicamentos, descrito pela resolução RE nº1/05 ANVISA determina a quantificação dos produtos de degradação, assim comoo método analítico utilizado correspondente. Como consequência, gerou-se a publicação do Informe Técnico nº 1/2008, com o objetivo de esclarecer procedimentos a serem realizados, nos casos em que a impureza ou padrões dos produtos de degradação não estão disponíveis. Diante das novas exigências, o delineamento do estudo torna-se uma das grandes dificuldades de sua realização, desafiando profissionais da área de desenvolvimento de produtos farmacêuticos.

The stability testing of drugs and medicines, as described in ANVISA resolution RE 1 / 05, specifies the quantitation of degradation products, as well as the analytical method concerned. As a consequence, Technical Report 1/2008 was published, with the aim of clarifying the procedures to be followed in cases where the impurity or patterns of degradation products are not available. In light of the new requirements, the study design constitutes one of the hardest problems for their implementation, facing professionals with new challenges in the area of pharmaceutical product development.